Zenith Renu G36137Recalls & reported problems
Cook Incorporated · Zenith Renu, AAA Ancillary Graft Main Body Extension · Class 3 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 1
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10827002361376), received between Oct 19, 2018 and Oct 19, 2018 — classified as 1 death.
The most frequently reported specific device problem is “Difficult or Delayed Separation” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Difficult or Delayed Separation1
Patient problems
- Death1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
DeathOct 19, 2018Difficult or Delayed Separation; Difficult or Delayed Separation
ADDITIONAL INFORMATION PROVIDED BY FACILITY 09NOV2018. IN (B)(6) 2011, A GORE C3 DEVICE HAD BEEN INSERTED (23MM MAIN BODY): 23MM X18CM X 14.5MM (INSERTED FROM THE RIGHT). 14.5MM LEFT LIMB. DUE TO A CONCERN ABOUT GROWING SAC SIZE (WITH DILATING NECK) AND CORRESPONDING DECREASED AREA OF SEAL, IT WAS DECIDED TO INSERT AN AORTIC CUFF. THE PATIENT WAS UNDER GENERAL ANAESTHETIC AND A RIGHT GROIN CUTDOWN HAD BEEN PERFORMED. A 6F SHEATH HAD BEEN INSERTED INTO THE LEFT FEMORAL ARTERY, THROUGH WHICH PIGTAIL RUNS WERE PERFORMED. JUST PRIOR, DURING AND IMMEDIATELY AFTER THE MALFUNCTION, THE PATIENT HAD REMAINED HEMODYNAMICALLY STABLE. THE DEVICE WAS INSERTED AND ANGIOGRAPHY PERFORMED. A BLACK INK MARKER WAS USED TO DELINEATE THE LEVEL OF THE LOWEST RENAL ARTERY BY DRAWING ITS LOCATION ON THE SCREEN. ENSURING THE MARKERS WERE CORRECT, THE RX1 GRAFT WAS DEPLOYED BY WITHDRAWING THE SHEATH. POSITION AT THIS POINT WAS SATISFACTORY. THE BLACK (PROXIMAL) TRIGGER WIRE RELEASE MECHANISM WAS REMOVED COMPLETELY. THE PIN VISE WAS SUBSEQUENTLY LOOSENED. AN ATTEMPT WAS MADE TO DEPLOY THE SUPRARENAL STENT BY ADVANCING THE TOP CAP INNER CANNULA. THE STENT DID NOT DEPLOY. AT THIS POINT, WE STOPPED AND CONSULTE
Patient problems: Death
MAUDE report 7986116 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page